Lung Cancer
October 09, 2024
Stereotactic vs Hypofractionated Radiotherapy for Inoperable Stage I NSCLC
The ASCO Post
October 09, 2024
Amivantamab-vmjw Plus Lazertinib Improves Long-Term Outcomes in First-Line Setting of EGFR-Mutant Advanced NSCLC
The ASCO Post
October 02, 2024
Immunotherapy/Chemoradiotherapy for Patients With Limited-Stage Small Cell Lung Cancer
The ASCO Post
Daily News
Stay up to date with the latest clinical headlines.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
September 30, 2024
Quality Improvements in Lung Cancer Surgery and Tumor Pathology May Extend Survival Postsurgery
The ASCO Post
September 27, 2024
Community-Academic Partnership May Successfully Reduce Radon-Related Lung Cancer Risk in Native Population
The ASCO Post
September 27, 2024
Datopotamab Deruxtecan vs Docetaxel in Previously Treated Advanced or Metastatic NSCLC
The ASCO Post
September 26, 2024
FDA Approves Osimertinib in Stage III NSCLC After Chemoradiotherapy
The ASCO Post
Advertisement
Recommendations
Advertisement